Glenmark Pharmaceuticals allots shares under employee stock option scheme

Glenmark Pharmaceuticals (BSE: GLENMARK) announced the allotment of 12,653 equity shares with a face value of Re. 1 each to eligible employees who exercised stock options under the company's Employee Stock Option Scheme 2016 ("ESOP 2016"). The decision was made during the Operations Committee meeting held on April 17, 2025. Following the allotment, the company's paid-up share capital increased from 28,21,88,156 equity shares to 28,22,00,809 equity shares aggregating to INR 28,22,00,809. The shares were priced at INR 600 per share (INR 1 par value with INR 599 premium). The allotment is compliant with SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021. The company has confirmed that the newly allotted shares rank equally with existing shares and have been approved for listing on the BSE and NSE.